From Breakthrough to Backlash: Novo Nordisk's Ozempic Faces USD 2 Billion Lawsuit Farhat Nasim22 Aug 2025 6:32 PM ISTNew Delhi: Novo Nordisk, the maker of the blockbuster diabetes drug Ozempic, is at the center of a brewing legal storm. Once celebrated as a...
Natco vs Novo Nordisk: Delhi High Court Directs Mediation in Wegovy Patent Dispute Farhat Nasim21 Aug 2025 9:26 PM ISTNew Delhi: Hyderabad-based Natco Pharma has filed a lawsuit against Danish drugmaker Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy...
Rs 180 Crore Ozempic Fraud: LOC Issued Against Pharma Firm CEO Parthika Patel20 Aug 2025 7:41 PM ISTNew Delhi: Delhi Police has issued a lookout circular (LOC) against Vicky Ramancha, Chief Executive Officer (CEO) of a pharmaceutical company, for...
Sun Pharma's Dapagliflozin, Glimepiride, Metformin FDC Fails to Secure CDSCO Panel Nod Over Safety, Utility Concerns Susmita Roy19 Aug 2025 3:11 PM ISTNew Delhi: Expressing doubts over the clinical utility of administering such a small dose of Glimepiride once daily, especially considering over the...
Regulatory Roadblock for Zydus: CDSCO Panel Halts MMRV Vaccine Trial, Seeks Adult Data Dr. Divya Colin18 Aug 2025 4:15 PM ISTNew Delhi: Zydus Lifesciences Limited's plan to conduct a Phase II/III clinical trial of its Measles, Mumps, Rubella and Varicella (MMRV) vaccine has...
Dr Reddy's Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML Susmita Roy17 Aug 2025 4:00 PM ISTNew Delhi: In a significant development, the pharmaceutical major, Dr. Reddy's Laboratories, has got the go-ahead from the Subject Expert Committee...
ITAT Grants Relief to Thermo Fisher in GSK-Linked Slump Sale, Allows Rs 3.07 Cr Depreciation on Goodwill Farhat Nasim16 Aug 2025 8:58 PM ISTMumbai: In a major relief for Thermo Fisher Scientific India Pvt. Ltd., the Income Tax Appellate Tribunal (ITAT), Mumbai "H" Bench, has allowed the...
Chemists' Body Warns of 55% Rise in Drug Abuse, Calls for Ban on 10-Minute Prescription Drug Delivery Susmita Roy15 Aug 2025 11:30 AM ISTNew Delhi: Speaking up against a worrying circumstance, the All India Organisation of Chemists and Druggists (AIOCD), representing over 12.40 lakh...
Setback to Torrent: CDSCO Panel Rejects Phase III Waiver Plea for Prucalopride Over Safety Data Gaps Susmita Roy14 Aug 2025 9:28 PM ISTNew Delhi: Citing that Torrent Pharmaceuticals has not presented adequate safety data on the synergistic effect of added excipients (propylene glycol,...
Pharma Firm, Director Under ED Lens Over Alleged Rs 60 Crore PNB Fraud Susmita Roy13 Aug 2025 7:40 PM ISTNew Delhi: As a part of an alleged multi-crore bank fraud, the Directorate of Enforcement (ED), Chandigarh, has begun investigating Ankur Drugs and...
UCPMP 2024: Govt Details Stricter Rules to Curb Gifts, Incentives from Pharma to Doctors Parthika Patel12 Aug 2025 2:28 PM ISTNew Delhi: During the last five years, a total of seven complaints were received under the Uniform Code of Pharmaceutical Marketing Practices (UCPMP),...
No More Physical WHO-GMP Certificate Applications After August 15: DCGI Alerts Pharma Firms Susmita Roy11 Aug 2025 5:45 AM ISTNew Delhi: Reaffirming that no further extensions will be granted, the Drugs Controller General of India (DCGI), Central Drugs Standard Control...
